We are live on ! Find out more
BFRI icon

Biofrontera

13 hedge funds and large institutions have $413K invested in Biofrontera in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 0.16%0.15% (-0.01%)

19% less funds holding

Funds holding: 1613 (-3)

21% less capital invested

Capital invested by funds: $520K → $413K (-$107K)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
6
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BFRI Hedge Fund Activity: Q2 2023 in Review

13 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q2 2023, worth a combined $413K — down 21% from $520K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BFRI and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $7.8K. The largest seller was BlackRock, cutting an estimated $20.9K.

  • 13 institutional investors held Biofrontera (BFRI) as of Q2 2023, down from 16 in Q1 2023.
  • Funds reported $413K of Biofrontera stock for Q2 2023, down 21% quarter-over-quarter.
  • 1 fund opened new Biofrontera positions in Q2 2023 and 4 closed out, a net change of -3 holders.
  • The largest Biofrontera buyer in Q2 2023 was Renaissance Technologies, an estimated $7.8K added.
  • The largest Biofrontera seller in Q2 2023 was BlackRock, an estimated $20.9K sold.

Based on aggregated 13F filings for Q2 2023.